相关产品推荐更多 >

SCAP2 polyclonal antibody (A01)/SCAP2 polyclonal antibody (A01)/SCAP2 polyclonal antibody (A01)
询价
MDM2 MaxPab兔源多克隆抗体
询价
Syt7 monoclonal antibody, clone S275-14 (P594)/Syt7 monoclonal antibody, clone S275-14 (P594)/Syt7 monoclonal antibody, clone S275-14 (P594)
询价
JmjC Domain-Containing Protein 5 (JMJD5) Antibody/JmjC Domain-Containing Protein 5 (JMJD5) Antibody/JmjC Domain-Containing Protein 5 (JMJD5) Antibody
询价
MINPP1 Antibody BIOTIN/MINPP1 Antibody BIOTIN
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
P815 cells
- 保存条件:
Store vial at 2-8℃
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
大鼠
- 应用范围:
E
- 抗体英文名:
CD49d Antibody [PS/2]
- 抗体名:
CD49d Antibody [PS/2]
- 规格:
0.5mg
CD49d 抗体 [PS/2],CD49d Antibody [PS/2],CD49d 抗体 [PS/2],CD49d Antibody [PS/2]
产品名称:CD49d 抗体 [PS/2]-CD49d Antibody [PS/2]
产品货号:PSI-98-549-0.5mg
产品规格:0.5mg
背景资料:VLA-4 belongs to the beta1-integrin family, which functions both as cell-matrix and cell-cell receptors. As a matrix receptor VLA-4 binds to an alternatively spliced domain of fibronectin, while as a cellular receptor it associates with its counter-receptor ligand VCAM-1. In addition to CD44/Pgp-1, VLA-4 has been shown to be important for lymphopoiesis, and is also believed to be important for extravasation of lymphocytes into sites of inflammation as a second signal in addition to LFA/ICAM-1. CD49d is expressed in low amounts on resting lymphocytes and monocytes, is absent or minimally detectable on stromal cells, whereas virtually all lymphoid and myeloid cells in bone marrow and in long-term culture are positive. Antibody PS/2 also reacts with human VLA-4.
保存建议:CD49d 抗体 [PS/2]-CD49d Antibody [PS/2]Store vial at 2-8℃
应用类型:E
点击:CD49d 抗体 [PS/2]-CD49d Antibody [PS/2]查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验-phosphoserine的抗体。 摘抄: Anti-Phosphothreonine (MAb) - CryptateThe anti-phosphothreonine antibody is a monoclonal antibody (clone 42H4) produced at Cell Signaling Technology (reference 9386). It recognizes phosphorylated threonine residues in a manner
Nature 综述导读:FDA 批准第 100 个抗体药物!抗体药物的研究方向在哪里?
批准了第 50 种抗体,距离第一个抗体已经过去了 29 年。2021 年 4 月,随着葛兰素史克 PD1 阻断剂 dostarlimab 的批准,抗体药物仅用了 6 年多的时间就达到了 100 个,进入了「百抗」新时代(图五)。 图五 Nature Reviews Drug Discovery 20, 10 (2021) 上面提到的 100 个抗体并不是单纯经典的单克隆的裸抗体(naked antibody),其中也包括了抗体片段已经工程化修饰抗体的各种偶联形式。其中包括有抗体药物偶联(ADC
反应发生的风险,故而在合成磷酸化多肽时,需要对氨基酸投料量、反应方法以及反应时长等进行优化调整以期达到更理想、更经济的合成效果。我们有针对性地对磷酸化多肽合成条件进行了探索和调整,采用最终的优化条件成功合成了含有多达六个磷酸化丝氨酸残基的多肽:FAM-Ahx-X(pS)XX(pS)X(pS)X(pS)XX(pS)X(pS)-NH2(客户肽,详细序列未给出;其氨基端标记FAM以进行荧光检测),经过RP-HPLC纯化后最终纯品的纯度高达95%(见Figure 3)。 参考文献: 1. P
技术资料暂无技术资料 索取技术资料






